Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-040695

Director acquired 625 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

STUELPNAGEL JOHN R · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-11 Grant or award : show line 1 in the form +625 406,616 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-06-11 Grant or award : show line 2 in the form Stock Option (right to buy) +1,563 $193.51 2031-06-11 1,563 1,563 D
Loading xslF345X03/doc4.xml…